Search

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.

… Monday, February 1, 2010 Summary In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States. People don’t usually think of math when

Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents.

… Thursday, November 8, 2018 Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents, according to data we presented at the American Society of Clinical Oncology’s annual meeting

In this Q&A we discuss MSK’s pioneering work in rectal MRI, how it differs from endorectal ultrasound (ERUS), its role in groundbreaking clinical trials for patients with rectal cancer, why expertise matters, and new frontiers for future improvements to rectal MRI.

… Thursday, June 26, 2025 A Q&A with Dr. Marc J. Gollub, MSK’s Director of Gastrointestinal Radiology Memorial Sloan Kettering Cancer Center (MSK) has one of the busiest rectal cancer practices and likely performs the most rectal magnetic resonance imaging (MRI) exams in the United States. In this Q&A

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

… Thursday, April 3, 2008 A study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells. Metastasis is the cause of approximately 90 percent of all cancer-related deaths.

People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.

… Tuesday, July 13, 2021 When it comes to body fat, what type you have and where it’s located is just as important as how much you have. Some people who are technically overweight are perfectly healthy because of where their fat is stored — subcutaneously (under the skin) rather than viscerally (around

Although distraction osteogenesis is commonly employed in regular orthopedic surgery, its use in cancer patients is currently limited. But research shows that these durable reconstructions can provide superior opportunities for better long-term limb function and growth in this cohort.

… Friday, August 10, 2018 Although distraction osteogenesis is commonly employed in regular orthopedic surgery, its use in cancer patients is currently limited. But research shows that these durable reconstructions can provide superior opportunities for better long-term limb function and growth compared

As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

… Wednesday, December 21, 2011 As an enduring tribute to a valued Board member and woman of incomparable grace, Memorial Sloan Kettering Cancer Center has joined with The Robertson Foundation to undertake two high-profile initiatives in honor of Josephine “Josie” Robertson: the Josie Robertson Surgery

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.

… Monday, April 1, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting

Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.

… Wednesday, November 17, 2021 Sometimes the best way to understand a biological process is to disrupt the normal process and analyze the result. That’s why Sloan Kettering Institute (SKI) researchers used a strain of mutant mice as a means to uncover new clues about the process of meiosis, which forms

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.

… Sunday, June 4, 2023 Breakthrough data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting press program and simultaneously published in  The New England Journal of Medicine (NEJM)  today found that vorasidenib